The Thunderbolt device from California-based Penumbra uses modulated aspiration to detect and remove blood clots. Back in January, Boston Scientific agreed to acquire Penumbra for approximately $14.5 billion.
Researchers tracked real-world data from more than 140 patients who originally received a transcatheter heart valve from Edwards Lifesciences, Medtronic or Boston Scientific.
The exam should be performed on patients with greater than 10 years of life expectancy and between the ages of 50 and 70, with earlier imaging recommended for black men.
Lawmakers have opted against authorizing funding for the Wasteful and Inappropriate Service Reduction Model, citing concerns it will overburden patients and providers.
The collaboration between the chipmaker and Abridge, a developer of generative AI for healthcare, will involve data-sharing to improve Nvidia’s general-purpose models, which in turn will be used to make Abridge’s clinical offerings more efficient.
Anthony Weinert, DPM, said the reputational harm he suffered as a result of the 2019 healthcare fraud charges has left him unable to find work, despite the case being voluntarily withdrawn by authorities.
The Kentucky-based insurance giant had owned a 40% stake in the hospice company, stemming from its 2021 acquisition of Kindred Healthcare. Humana said a “consortium of investors" is making the buy, but few details were revealed.
A total of 10 professional associations—also representing pain medicine, anesthesia and rehab specialists—recently messaged more than a dozen payers across the U.S.
The uptick came during a time when the number of ED episodes increased by only 8% at the same institution, with defensive medicine one possible driver.
RP said it has two more residency program slated to launch in 2026, with its research institute developing curriculum focused on artificial intelligence and the business of imaging.
The Thunderbolt device from California-based Penumbra uses modulated aspiration to detect and remove blood clots. Back in January, Boston Scientific agreed to acquire Penumbra for approximately $14.5 billion.
Researchers tracked real-world data from more than 140 patients who originally received a transcatheter heart valve from Edwards Lifesciences, Medtronic or Boston Scientific.
